Because murine endothelial OASL1-mediated atheroprotective effects are conserved in human OASL, controlling the OASL-miR-584-eNOS regulatory axis may represent an effective therapeutic strategy for treating human atherosclerosis and other vascular diseases mediated by endothelial dysfunction. The gene discussed is NOS3; the disease is atherosclerosis.